Discovery of hydrazide-based pyridazino[4,5-b]indole scaffold as a new phosphoinositide 3-kinase (PI3K) inhibitor for breast cancer therapy.
RSC Adv
; 10(33): 19534-19541, 2020 May 20.
Article
in En
| MEDLINE
| ID: mdl-35515454
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
RSC Adv
Year:
2020
Document type:
Article
Country of publication:
United kingdom